Crescent Capital BDC, Inc. (NASDAQ:CCAP) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 38.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,386 shares of the company’s stock after selling 14,311 shares during the period. JPMorgan Chase & Co. owned 0.06% of Crescent Capital BDC worth $433,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of CCAP. Sun Life Financial Inc. grew its holdings in shares of Crescent Capital BDC by 20.7% during the third quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock worth $41,187,000 after buying an additional 382,542 shares during the last quarter. Kovitz Investment Group Partners LLC acquired a new stake in Crescent Capital BDC during the 3rd quarter worth approximately $4,878,000. International Assets Investment Management LLC purchased a new position in shares of Crescent Capital BDC in the 3rd quarter valued at approximately $1,899,000. Franklin Resources Inc. increased its holdings in shares of Crescent Capital BDC by 35.2% in the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock valued at $4,726,000 after purchasing an additional 66,713 shares during the period. Finally, Millennium Management LLC raised its stake in shares of Crescent Capital BDC by 31.9% during the second quarter. Millennium Management LLC now owns 268,097 shares of the company’s stock worth $5,035,000 after purchasing an additional 64,902 shares during the last quarter. 49.46% of the stock is owned by hedge funds and other institutional investors.

Crescent Capital BDC Trading Up 0.8 %

NASDAQ:CCAP opened at $19.44 on Wednesday. The company has a market capitalization of $720.45 million, a PE ratio of 7.62 and a beta of 0.81. Crescent Capital BDC, Inc. has a 52-week low of $15.91 and a 52-week high of $20.03. The stock has a fifty day simple moving average of $19.37 and a 200-day simple moving average of $18.76. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Tuesday, November 12th. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.07. The firm had revenue of $51.63 million for the quarter, compared to analysts’ expectations of $48.76 million. Crescent Capital BDC had a return on equity of 12.20% and a net margin of 47.06%. During the same quarter in the prior year, the firm earned $0.59 EPS. On average, equities research analysts expect that Crescent Capital BDC, Inc. will post 2.43 earnings per share for the current fiscal year.

Crescent Capital BDC Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.68 annualized dividend and a dividend yield of 8.64%. Crescent Capital BDC’s dividend payout ratio (DPR) is 65.88%.

Wall Street Analysts Forecast Growth

Separately, Keefe, Bruyette & Woods lifted their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Crescent Capital BDC presently has an average rating of “Moderate Buy” and an average price target of $19.17.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.